Medication Assisted Treatment

In the best of circumstances, ending opioid or alcohol addiction is a difficult, painful process. In the most challenging of circumstances, the addictions are almost impossible to overcome. Medication-Assisted Treatment (MAT) is often a critical tool that, when combined with therapy and other supports, can help a person enter into and maintain recovery. If you or someone you know might benefit from Medication Assisted Treatment (MAT) services, contact us today to learn more about how we can help.

How It Works

Medication Assisted Treatment (MAT) is a proven, effective treatment. In MAT, clients receive medication sometimes daily or monthly that curbs cravings and the body’s need for opioids or alcohol. For many, it reduces:

  • Relapse, compared to abstinence-only (“going cold turkey”)

  • Cravings

  • Anxiety

  • Sleep disturbances

Our MAT team, comprised of Medical Doctors and Advanced Nurse Practitioners, licensed alcohol and drug counselors, licensed social workers, medical assistants, and recovery support workers, structures treatment to meet the patient’s needs or goals. A multi-pronged approach helps patients achieve—and sustain—recovery. Patients may be encouraged to pursue other treatments, such as:

  • Residential rehab treatment  

  • Outpatient counseling or behavioral therapy 

  • Intensive Outpatient treatment 

Patients in these programs have access to MAT.

Treatment Medications

Our medication may include:

  • Suboxone

  • Subutex

  • Vivitrol

  • Subclade

Insurance & Enrollment

Thanks to the support of many donors and funders, we offer care to all those in need, including those without insurance or ability to pay for services, using a sliding fee scale based on income. We accept most insurances, including Medicaid, Medicare, and private insurance. Please contact us with any questions about insurance or payment, or to schedule an appointment with our Patient Navigator, who can help you understand and apply for any insurance you may be eligible to receive.